Belgian data of ODYSSEY APPRISE: stringent LDL‐c targets are in reach when using all available tools-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Belgian data of ODYSSEY APPRISE: stringent LDL‐c targets are in reach when using all available tools

Published:2021-09-30 Issue:12 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clinical Practice

Author:

Verdickt Sébastien¹,Van der Schueren Bart¹²,Vangoitsenhoven Roman¹²,Descamps Olivier S.³⁴,Mertens Ann¹²

Affiliation:

1. Department of Diabetes and Endocrinology University Hospitals of Leuven Leuven Belgium

2. Clinical and Experimental Endocrinology KU Leuven Leuven Belgium

3. Department of Internal Medicine Centres Hospitaliers Jolimont Haine‐Saint‐Paul Belgium

4. Department of Cardiology UCL Cliniques Universitaires Saint‐Luc Bruxelles Belgium

Funder

Sanofi

Regeneron Pharmaceuticals

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14916

Reference18 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

4. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

5. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study of people with familial hypercholesterolaemia in a Belgian lipid clinic;Acta Cardiologica;2023-10-26

2. Long-term safety and effectiveness of alirocumab and evolocumab in familial hypercholesterolemia (FH) in Belgium;Acta Cardiologica;2023-09-28

3. A subgroup analysis of the ODYSSEY APPRISE study: Safety and efficacy of alirocumab in the Italian cohort;Nutrition, Metabolism and Cardiovascular Diseases;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3